title: The incidence of co-existing BCR-ABL1 and JAK2 V617F rearrangements: implications for molecular diagnostics.
authors.forename: Sarah L
authors.initials: SL
authors.lastname: McCarron
authors.forename: Karl
authors.initials: K
authors.lastname: Haslam
authors.forename: Mireille
authors.initials: M
authors.lastname: Crampe
authors.forename: Stephen E
authors.initials: SE
authors.lastname: Langabeer
mesh_terms: D019943:Amino Acid Substitution; D014408:Biomarkers, Tumor / Q000235:genetics*; D016044:Fusion Proteins, bcr-abl / Q000235:genetics*; D015321:Gene Rearrangement; D019337:Hematologic Neoplasms / Q000175:diagnosis / Q000235:genetics* / Q000473:pathology; D006801:Humans; D053614:Janus Kinase 2 / Q000235:genetics*; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000175:diagnosis / Q000235:genetics* / Q000473:pathology; D025202:Molecular Diagnostic Techniques; D009154:Mutation; D022423:Myeloid Cells / Q000378:metabolism / Q000473:pathology; D011505:Protein-Tyrosine Kinases / Q000235:genetics*
chemical_list: D014408:Biomarkers, Tumor; D011505:Protein-Tyrosine Kinases; D016044:Fusion Proteins, bcr-abl; C507924:JAK2 protein, human; D053614:Janus Kinase 2